Martin F. Haslanger
Director/Board Member at Apexian Pharmaceuticals, Inc.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Tim Tichenor | M | - |
Apexian Pharmaceuticals, Inc.
Apexian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Apexian Pharmaceuticals, Inc. discovers, develops and commercializes novel pharmaceuticals products. It offers pharmaceutical products for the treatment of pancreatic cancer, blood cancer, brain tumors, ovarian cancer, age-related macular degeneration, and diabetic retinopathy. The company was founded by Mark R. Kelley in 2005 and is headquartered in Indianapolis, IN. | - |
David Ricks | M | 56 | 28 years | |
David A. Broecker | M | 63 |
Apexian Pharmaceuticals, Inc.
Apexian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Apexian Pharmaceuticals, Inc. discovers, develops and commercializes novel pharmaceuticals products. It offers pharmaceutical products for the treatment of pancreatic cancer, blood cancer, brain tumors, ovarian cancer, age-related macular degeneration, and diabetic retinopathy. The company was founded by Mark R. Kelley in 2005 and is headquartered in Indianapolis, IN. | 28 years |
Mark R. Kelley | M | - |
Apexian Pharmaceuticals, Inc.
Apexian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Apexian Pharmaceuticals, Inc. discovers, develops and commercializes novel pharmaceuticals products. It offers pharmaceutical products for the treatment of pancreatic cancer, blood cancer, brain tumors, ovarian cancer, age-related macular degeneration, and diabetic retinopathy. The company was founded by Mark R. Kelley in 2005 and is headquartered in Indianapolis, IN. | 19 years |
John Barnard | M | - |
Apexian Pharmaceuticals, Inc.
Apexian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Apexian Pharmaceuticals, Inc. discovers, develops and commercializes novel pharmaceuticals products. It offers pharmaceutical products for the treatment of pancreatic cancer, blood cancer, brain tumors, ovarian cancer, age-related macular degeneration, and diabetic retinopathy. The company was founded by Mark R. Kelley in 2005 and is headquartered in Indianapolis, IN. | - |
James H. Wikel | M | - |
Apexian Pharmaceuticals, Inc.
Apexian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Apexian Pharmaceuticals, Inc. discovers, develops and commercializes novel pharmaceuticals products. It offers pharmaceutical products for the treatment of pancreatic cancer, blood cancer, brain tumors, ovarian cancer, age-related macular degeneration, and diabetic retinopathy. The company was founded by Mark R. Kelley in 2005 and is headquartered in Indianapolis, IN. | - |
Alonzo Weems | M | - | 27 years | |
Homer Pearce | M | 71 |
Apexian Pharmaceuticals, Inc.
Apexian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Apexian Pharmaceuticals, Inc. discovers, develops and commercializes novel pharmaceuticals products. It offers pharmaceutical products for the treatment of pancreatic cancer, blood cancer, brain tumors, ovarian cancer, age-related macular degeneration, and diabetic retinopathy. The company was founded by Mark R. Kelley in 2005 and is headquartered in Indianapolis, IN. | - |
Roger D. Miller | M | 74 |
Apexian Pharmaceuticals, Inc.
Apexian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Apexian Pharmaceuticals, Inc. discovers, develops and commercializes novel pharmaceuticals products. It offers pharmaceutical products for the treatment of pancreatic cancer, blood cancer, brain tumors, ovarian cancer, age-related macular degeneration, and diabetic retinopathy. The company was founded by Mark R. Kelley in 2005 and is headquartered in Indianapolis, IN. | 10 years |
William L. Current | M | - |
Apexian Pharmaceuticals, Inc.
Apexian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Apexian Pharmaceuticals, Inc. discovers, develops and commercializes novel pharmaceuticals products. It offers pharmaceutical products for the treatment of pancreatic cancer, blood cancer, brain tumors, ovarian cancer, age-related macular degeneration, and diabetic retinopathy. The company was founded by Mark R. Kelley in 2005 and is headquartered in Indianapolis, IN. | 10 years |
Roberta Smithey | F | - |
Apexian Pharmaceuticals, Inc.
Apexian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Apexian Pharmaceuticals, Inc. discovers, develops and commercializes novel pharmaceuticals products. It offers pharmaceutical products for the treatment of pancreatic cancer, blood cancer, brain tumors, ovarian cancer, age-related macular degeneration, and diabetic retinopathy. The company was founded by Mark R. Kelley in 2005 and is headquartered in Indianapolis, IN. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Randall L. Tobias | M | - | 12 years | |
William P. Janzen | M | - |
Amphora Discovery Corp.
Amphora Discovery Corp. Pharmaceuticals: MajorHealth Technology Amphora Discovery Corp. develops and manufactures pharmaceutical products. It provides custom assay development and enzymology services. The company provides drug discovery contract research services, HTS, profiling and lead generation services. The company was founded in September 2001 and is headquartered in Durham, NC. | 8 years |
Susan Mahony | M | 59 | 18 years | |
Nicholas C. Hodge | M | - |
Amphora Discovery Corp.
Amphora Discovery Corp. Pharmaceuticals: MajorHealth Technology Amphora Discovery Corp. develops and manufactures pharmaceutical products. It provides custom assay development and enzymology services. The company provides drug discovery contract research services, HTS, profiling and lead generation services. The company was founded in September 2001 and is headquartered in Durham, NC. | - |
Kathi P. Seifert | F | 74 | 26 years | |
James Cornelius | M | 81 | 12 years | |
Win Bischoff | M | 81 | 14 years | |
Gregory Davis | M | 70 | 20 years | |
Melissa Barnes | F | 55 | 27 years | |
Alfred G. Gilman | M | 82 | - | |
Aarti Shah | M | 59 | 27 years | |
Anat Ashkenazi | F | 51 | 23 years | |
Diana McKenzie | F | 59 | 12 years | |
Franklyn Prendergast | M | 79 | 22 years | |
Jeffrey Henderson | M | 59 | 7 years | |
Keith E. Brauer | M | 75 | 6 years | |
Webster Dunbar | M | 62 | 5 years | |
Robert A. Armitage | M | 75 | 13 years | |
Timothy Garnett | M | 63 | 23 years | |
Bing Li | M | 55 | 7 years | |
Richard Ernest Gilbert | M | - | 12 years | |
Joe C. Cook | M | 82 | - | |
Christian Bloomgren | M | - | 2 years | |
Michael Schröter | M | - | 2 years | |
Scott A. Byrd | M | 54 | 14 years | |
Karim Bitar | M | 59 | 15 years | |
Patricia A. Johnston | M | - | 4 years | |
David Gonyer | M | 60 | 9 years | |
T. Spencer Williamson | M | - | 3 years | |
Robert Baughman | M | - | - | |
Joseph B. Kleine | M | 60 | 11 years | |
Zhenyu Xu | M | 53 | 11 years | |
Pankaj Mohan | M | 60 | 3 years | |
Wael Kanaan | M | - | - | |
Jamie Dananberg | M | 66 | 12 years | |
Richard Buckley | M | 55 | 7 years | |
Kimberly Mathisen, MBA | - | - | 12 years | |
Allen Melemed | M | 60 | 22 years | |
Frank Cunningham | M | - | - | |
Yao Chang Xu | M | 67 | 13 years | |
Ann Cunningham | F | 56 | 14 years | |
Maria Rivas | M | 60 | 11 years | |
Kathryn Dickey Karol | F | - | 12 years | |
Gail H. Cassell | M | 77 | - | |
J. Ware | M | 71 | 17 years | |
Maurice Horsten | M | 57 | - | |
Michael Bumby | M | 60 | 11 years | |
Casey Logan | M | 52 | 6 years | |
Curtis Oltmans | M | 60 | 13 years | |
Catherine A. Melfi | M | 64 | 16 years | |
Marc M. P. de Garidel | M | 66 | 12 years | |
Thomas L. Greer | M | - | 1 years | |
Lisa Guttman | F | - | 10 years | |
Oranee T. Daniels | M | - | 3 years | |
Eurelio Cavalier | M | 91 | 36 years | |
Charles E. Golden | M | 77 | 10 years | |
Eugene L. Step | M | 94 | 19 years | |
Ronald W. Dollens | M | 77 | 3 years | |
Don W. Grimm | M | 82 | - | |
George Myles Cordell Fisher | M | 84 | - | |
Michael R. Jirousek | M | 65 | 5 years | |
Robert Zerbe | M | 73 | 11 years | |
James C. Lancaster | M | 77 | 6 years | |
John W. Price | M | 79 | 17 years | |
Carol Gallagher | M | 59 | 8 years | |
Frederick W. Ruebeck | M | 85 | 11 years | |
Pierre V. Trân | M | 64 | 12 years | |
John E. Voris | M | 76 | 22 years | |
Richard DiMarchi | M | 71 | 11 years | |
Michael E. Hanson | M | 74 | 24 years | |
Brett L. Schmidli | M | 72 | 10 years | |
Charl van Zyl | M | 57 | 9 years | |
Scott Syphax | M | 60 | 2 years | |
Martin Babler | M | 59 | 7 years | |
Gary Seelhorst | M | 52 | 2 years | |
Shu Hui Chen | M | 61 | 6 years | |
Neal Fowler | M | 62 | 13 years | |
Karl E. White | M | - | 4 years | |
James A. Harper | M | 77 | 10 years | |
James Posada | M | - | 4 years | |
Morris Z. Rosenberg | M | 64 | 3 years | |
Bryan Dunnivant | M | - | 3 years | |
William Chin | M | 76 | - | |
Arnold A. Pinkston | M | 65 | 11 years | |
Firas Raouf | M | - | 3 years | |
Scott Jackson | M | 59 | 5 years | |
Dominick Colangelo | M | 60 | - | |
John T. Boris | M | - | 10 years | |
Jesper Gromada | M | - | 6 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Martin F. Haslanger
- Personal Network